Journals / İstanbul Tıp Fakültesi Dergisi / 2017 / Cilt: 80 - Sayı: 2

OCCULT HEPATITIS B VIRUS INFECTION: MOLECULAR MECHANISMS AND CLINICAL SIGNIFICANCE

OKÜLT HEPATİT B VİRUS ENFEKSİYONU: MOLEKÜLER MEKANİZMALAR VE KLİNİK ÖNEMİ

Pages
71–81
Publication Date
2017-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Hepatitis B virüs; occult hepatitis B virus infection; transmission; reactivation; chronic liver disease; hepatocellular carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Occult Hepatitis B Virus (HBV) infection (OBI) is defined as the long-lasting persistence of HBV genomes in the hepatocytes of individuals testing negative for HBV surface antigen (HBsAg) by currently available assays and usually for serum HBV DNA.
📊
Key Findings & Data:Also OBİ infection has been hypothesized to be a significant risk factor contributing to the progression of chronic liver diseases (CLD) with increased risk for hepatocellular carcinoma (HCC) which may lead to an increased progression of liver diseases.
💡
Conclusion & Impact:Keywords: Hepatitis B virüs; occult hepatitis B virus infection; transmission; reactivation; chronic liver disease; hepatocellular carcinoma.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit B virüs · okült hepatit B virüs infeksiyonu · bulaş

Abstract

Occult Hepatitis B Virus (HBV) infection (OBI) is defined as the long-lasting persistence of HBV genomes in the hepatocytes of individuals testing negative for HBV surface antigen (HBsAg) by currently available assays and usually for serum HBV DNA. OBI is considered as the possible phase in the natural history of chronic HBV infection that the host’s immune surveillance and epigenetic mechanisms are likely involved. Clinical impact of OB is that it can be transmitted (i.e., through blood transfusion, by liver organ transplantation, hemodialysis and parturition) causing classic forms of hepatitis B in newly infected individuals. The development of an immunosuppressive status may induce OBI reactivation and development of acute and often severe hepatitis. OBI can favor the progression of liver fibrosis. Also OBİ infection has been hypothesized to be a significant risk factor contributing to the progression of chronic liver diseases (CLD) with increased risk for hepatocellular carcinoma (HCC) which may lead to an increased progression of liver diseases. Although OBI is considered a phase in the natural history of HBV, the molecular mechanisms leading to its occurrence and its contribution to HCC development are yet poorly understood. In this review, it is aimed to examine clinical importance, epidemiological aspects and laboratory diagnosis of OBI in recent literature. Keywords: Hepatitis B virüs; occult hepatitis B virus infection; transmission; reactivation; chronic liver disease; hepatocellular carcinoma.

Özet

Okült Hepatitis B Virüs (HBV) infeksiyonu (OBİ) serum HBV DNA statüsü dikkate alınmaksızın mevcut serolojik testler ile HBV yüzey antijeni (HBsAg) negatif tespit edilen bireylerin karaciğerin de HBV genomunun uzun süreli persistan varlığı olarak tanımlanır. OBİ virüse ve infekte bireye ait faktörler ile çevresel faktörlerin zemininde gelişen genetik, epigenetik ve immünolojik mekanizmaların karşılıklı etkileşimi ile şekillenen, HBV infeksiyonunun doğal seyri içerisinde yer alan muhtemel safhalarından biri olarak kabul edilir. OBİ klinik açıdan; okült virüsün kan transfüzyonu, doğum, hemodiyaliz ve ortotopik karaciğer gibi organ nakli yolu ile bulaşını takiben alıcıda tipik yeni HBV infeksiyonuna neden olabilmesi, immünsüpresyon koşullarında OBİ reaktivasyonu ve takiben HBV ilişkili (akut ve fulminan hepatit) karaciğer hastalıkları, kronik karaciğer hastalıklarının (KKH) progresyonu üzerine etkisi ile özellikle hepatoselüler karsinoma (HSK) için artan bir risk faktörü olduğu yönünde hipotez uyarınca yoğun bir tartışma ve araştırma konusudur. Buna karşın gerek HBV infeksiyonunun bu özgün formuna neden olan gerekse ilişkili olduğu karaciğer hastalıklarının patogenezinde rol alan moleküler mekanizmalar henüz tam olarak aydınlatılamamıştır. Bu derlemede OBİ’nin klinik önemi, epidemiyolojik özellikleri ve laboratuar tanısına yönelik bilimsel literatürün gözden geçirilmesi amaçlanmıştır. Anahtar Kelimeler: Hepatit B virüs; okült hepatit B virüs infeksiyonu; bulaş; reaktivasyon; kronik karaciğer hastalığı; hepatoselüler karsinoma.

🔖

Cite This Article

ÇAKAL, B. (2017). OCCULT HEPATITIS B VIRUS INFECTION: MOLECULAR MECHANISMS AND CLINICAL SIGNIFICANCE. İstanbul Tıp Fakültesi Dergisi, Cilt: 80 - Sayı: 2, 71–81. https://ajindex.com/articles/92950

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. World Health Organization. http://www.who.int/mediacentre/factsheets/fs204/en/ erişim 12 Ocak 2015
  2. World Health Organization. http://www.who.int/mediacentre/factsheets/fs297/en/ erişim 12 Ocak 2015
  3. Shi J, Zhu L, Liu S, Xie WF. A Metaanalysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607–12
  4. Chang MH. Cancer prevention by vaccination against hepatitis B. Recent Results. Cancer Res 2009; 181: 85-94
  5. Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002; 181–182: 35–8
  6. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 62: 2089–94
  7. Ganem D, Prince AM. Hepatitis B virus infection natural history and clinical consequences. N Engl J Med 2004;350: 1118–29
  8. Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, et al. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP). Am J Gastroenterol 1998; 93: 896–900
  9. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-7
  10. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002; 2: 479-86
  11. Pollicino T, Saitta C. Occult hepatitis B virus and hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5951-61
  12. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 2012;25:142-63
  13. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160–70
  14. Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009; 58: 383–8
  15. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Br_echot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology 2001;34: 94–203
  16. Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, et al. Previous or occult hepatitis B virus infection in hepatitis B surface antigen negative and anti-hepatitis C negative patients with hepatocellular carcinoma. Surg Today 2004; 34: 842–8
  17. Pollicino T, Saitta C, Raimondo G. Hepatocellular car